State of Wisconsin Investment Board’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-21,500
| Closed | -$112K | – | 2463 |
|
2023
Q4 | $112K | Buy |
21,500
+8,700
| +68% | +$45.5K | ﹤0.01% | 2258 |
|
2023
Q3 | $202K | Sell |
12,800
-11,030
| -46% | -$174K | ﹤0.01% | 2238 |
|
2023
Q2 | $463K | Buy |
23,830
+1,450
| +6% | +$28.2K | ﹤0.01% | 1848 |
|
2023
Q1 | $635K | Sell |
22,380
-10,012
| -31% | -$284K | ﹤0.01% | 1740 |
|
2022
Q4 | $947K | Buy |
32,392
+17,681
| +120% | +$517K | ﹤0.01% | 1521 |
|
2022
Q3 | $389K | Buy |
14,711
+2,808
| +24% | +$74.3K | ﹤0.01% | 2091 |
|
2022
Q2 | $529K | Sell |
11,903
-2,097
| -15% | -$93.2K | ﹤0.01% | 2052 |
|
2022
Q1 | $693K | Hold |
14,000
| – | – | ﹤0.01% | 1720 |
|
2021
Q4 | $713K | Hold |
14,000
| – | – | ﹤0.01% | 1552 |
|
2021
Q3 | $781K | Hold |
14,000
| – | – | ﹤0.01% | 1519 |
|
2021
Q2 | $599K | Hold |
14,000
| – | – | ﹤0.01% | 1633 |
|
2021
Q1 | $584K | Sell |
14,000
-1,600
| -10% | -$66.7K | ﹤0.01% | 1545 |
|
2020
Q4 | $726K | Sell |
15,600
-1,900
| -11% | -$88.4K | ﹤0.01% | 1408 |
|
2020
Q3 | $743K | Buy |
17,500
+3,400
| +24% | +$144K | ﹤0.01% | 1355 |
|
2020
Q2 | $677K | Hold |
14,100
| – | – | ﹤0.01% | 1333 |
|
2020
Q1 | $649K | Sell |
14,100
-300
| -2% | -$13.8K | ﹤0.01% | 1276 |
|
2019
Q4 | $865K | Hold |
14,400
| – | – | ﹤0.01% | 1273 |
|
2019
Q3 | $815K | Hold |
14,400
| – | – | ﹤0.01% | 1183 |
|
2019
Q2 | $802K | Buy |
14,400
+300
| +2% | +$16.7K | ﹤0.01% | 1192 |
|
2019
Q1 | $712K | Buy |
14,100
+3,200
| +29% | +$162K | ﹤0.01% | 1246 |
|
2018
Q4 | $439K | Buy |
10,900
+300
| +3% | +$12.1K | ﹤0.01% | 1351 |
|
2018
Q3 | $735K | Hold |
10,600
| – | – | ﹤0.01% | 1301 |
|
2018
Q2 | $802K | Buy |
10,600
+4,600
| +77% | +$348K | ﹤0.01% | 1244 |
|
2018
Q1 | $316K | Hold |
6,000
| – | – | ﹤0.01% | 1357 |
|
2017
Q4 | $321K | Hold |
6,000
| – | – | ﹤0.01% | 1354 |
|
2017
Q3 | $358K | Hold |
6,000
| – | – | ﹤0.01% | 1355 |
|
2017
Q2 | $473K | Buy |
+6,000
| New | +$473K | ﹤0.01% | 1296 |
|